Exploring and Exploiting Genetic Risk for Psychiatric Disorders
Herausgeber: Binder, Elisabeth; Gordon, Joshua A.
Exploring and Exploiting Genetic Risk for Psychiatric Disorders
Herausgeber: Binder, Elisabeth; Gordon, Joshua A.
- Broschiertes Buch
- Merkliste
- Auf die Merkliste
- Bewerten Bewerten
- Teilen
- Produkt teilen
- Produkterinnerung
- Produkterinnerung
"This volume examines the state of psychiatric genetics and charts a path forward for further discovery and translation"-- Provided by publisher.
Andere Kunden interessierten sich auch für
- Sarah FayPathological30,99 €
- Richard E. Cytowic (Doctor)Synesthesia23,99 €
- Matthew Ratcliffe (University of York Professor)Real Hallucinations48,99 €
- Andy NormanMental Immunity29,99 €
- Stijn VanheuleWhy Psychosis Is Not So Crazy24,99 €
- Marc WittmannAltered States of Consciousness13,99 €
- David Marr (Late Professor of Psychology at the Massachusetts InstiVision54,99 €
-
-
-
"This volume examines the state of psychiatric genetics and charts a path forward for further discovery and translation"-- Provided by publisher.
Produktdetails
- Produktdetails
- Strungmann Forum Reports
- Verlag: MIT Press Ltd
- Seitenzahl: 340
- Erscheinungstermin: 10. Oktober 2023
- Englisch
- Abmessung: 152mm x 229mm x 22mm
- Gewicht: 454g
- ISBN-13: 9780262547383
- ISBN-10: 0262547384
- Artikelnr.: 68271115
- Herstellerkennzeichnung
- Libri GmbH
- Europaallee 1
- 36244 Bad Hersfeld
- gpsr@libri.de
- Strungmann Forum Reports
- Verlag: MIT Press Ltd
- Seitenzahl: 340
- Erscheinungstermin: 10. Oktober 2023
- Englisch
- Abmessung: 152mm x 229mm x 22mm
- Gewicht: 454g
- ISBN-13: 9780262547383
- ISBN-10: 0262547384
- Artikelnr.: 68271115
- Herstellerkennzeichnung
- Libri GmbH
- Europaallee 1
- 36244 Bad Hersfeld
- gpsr@libri.de
edited Joshua A. Gordon and Elisabeth B. Binder
List of Contributors vii
Preface xi
1 Exploring and Exploiting Genetic Risk for Psychiatric Disorders 1
Gene Discovery
2 Delineating Additional Risk Factors 13
3 Data Collection: Next Steps in Psychiatric Genetics 39
4 Environmental Risk and Gene-Environment Relationships in Psychiatric
Disorders 51
Understanding Rare Variation
5 Rare Variants: Shared Paths for Therapeutic Development and
Neurobiological Investigation 69
6 Promises and Challenges of Precision Medicine in Rare Neurodevelopmental
Disorders 103
7 Experimental Model Systems for Rare and Common Variants 117
Understanding Common Variation
8 Common Alleles: Next Steps in the Study of Common Variants 131
9 Hypotheses of How Common Variants Create Risk for Psychiatric Disorders
155
10 From Common Variant to Function: State-of-the-Art Approaches 167
11 Contextualizing Convergent Common Variant Mechanisms through Systems
Biology 179
Clinical Considerations
12 Maximizing Near-Term Clinical Opportunities for Psychiatric Genetics 201
13 The Use of Polygenic Risk Scores in Clinical Psychiatry: Opportunities
and Obstacles 219
14 Ethical Challenges Associated with Advances in Genetic Prediction of
Neuropsychiatric Disorders 237
15 Psychiatric Genetic Counseling: Next Steps 249
16 Concluding Summary 261
Bibliography 267
Subject Index 319
Strungmann Forum Report Series 325
Preface xi
1 Exploring and Exploiting Genetic Risk for Psychiatric Disorders 1
Gene Discovery
2 Delineating Additional Risk Factors 13
3 Data Collection: Next Steps in Psychiatric Genetics 39
4 Environmental Risk and Gene-Environment Relationships in Psychiatric
Disorders 51
Understanding Rare Variation
5 Rare Variants: Shared Paths for Therapeutic Development and
Neurobiological Investigation 69
6 Promises and Challenges of Precision Medicine in Rare Neurodevelopmental
Disorders 103
7 Experimental Model Systems for Rare and Common Variants 117
Understanding Common Variation
8 Common Alleles: Next Steps in the Study of Common Variants 131
9 Hypotheses of How Common Variants Create Risk for Psychiatric Disorders
155
10 From Common Variant to Function: State-of-the-Art Approaches 167
11 Contextualizing Convergent Common Variant Mechanisms through Systems
Biology 179
Clinical Considerations
12 Maximizing Near-Term Clinical Opportunities for Psychiatric Genetics 201
13 The Use of Polygenic Risk Scores in Clinical Psychiatry: Opportunities
and Obstacles 219
14 Ethical Challenges Associated with Advances in Genetic Prediction of
Neuropsychiatric Disorders 237
15 Psychiatric Genetic Counseling: Next Steps 249
16 Concluding Summary 261
Bibliography 267
Subject Index 319
Strungmann Forum Report Series 325
List of Contributors vii
Preface xi
1 Exploring and Exploiting Genetic Risk for Psychiatric Disorders 1
Gene Discovery
2 Delineating Additional Risk Factors 13
3 Data Collection: Next Steps in Psychiatric Genetics 39
4 Environmental Risk and Gene-Environment Relationships in Psychiatric
Disorders 51
Understanding Rare Variation
5 Rare Variants: Shared Paths for Therapeutic Development and
Neurobiological Investigation 69
6 Promises and Challenges of Precision Medicine in Rare Neurodevelopmental
Disorders 103
7 Experimental Model Systems for Rare and Common Variants 117
Understanding Common Variation
8 Common Alleles: Next Steps in the Study of Common Variants 131
9 Hypotheses of How Common Variants Create Risk for Psychiatric Disorders
155
10 From Common Variant to Function: State-of-the-Art Approaches 167
11 Contextualizing Convergent Common Variant Mechanisms through Systems
Biology 179
Clinical Considerations
12 Maximizing Near-Term Clinical Opportunities for Psychiatric Genetics 201
13 The Use of Polygenic Risk Scores in Clinical Psychiatry: Opportunities
and Obstacles 219
14 Ethical Challenges Associated with Advances in Genetic Prediction of
Neuropsychiatric Disorders 237
15 Psychiatric Genetic Counseling: Next Steps 249
16 Concluding Summary 261
Bibliography 267
Subject Index 319
Strungmann Forum Report Series 325
Preface xi
1 Exploring and Exploiting Genetic Risk for Psychiatric Disorders 1
Gene Discovery
2 Delineating Additional Risk Factors 13
3 Data Collection: Next Steps in Psychiatric Genetics 39
4 Environmental Risk and Gene-Environment Relationships in Psychiatric
Disorders 51
Understanding Rare Variation
5 Rare Variants: Shared Paths for Therapeutic Development and
Neurobiological Investigation 69
6 Promises and Challenges of Precision Medicine in Rare Neurodevelopmental
Disorders 103
7 Experimental Model Systems for Rare and Common Variants 117
Understanding Common Variation
8 Common Alleles: Next Steps in the Study of Common Variants 131
9 Hypotheses of How Common Variants Create Risk for Psychiatric Disorders
155
10 From Common Variant to Function: State-of-the-Art Approaches 167
11 Contextualizing Convergent Common Variant Mechanisms through Systems
Biology 179
Clinical Considerations
12 Maximizing Near-Term Clinical Opportunities for Psychiatric Genetics 201
13 The Use of Polygenic Risk Scores in Clinical Psychiatry: Opportunities
and Obstacles 219
14 Ethical Challenges Associated with Advances in Genetic Prediction of
Neuropsychiatric Disorders 237
15 Psychiatric Genetic Counseling: Next Steps 249
16 Concluding Summary 261
Bibliography 267
Subject Index 319
Strungmann Forum Report Series 325